Who invested in Ollin Biosciences?
Ollin Biosciences's investors include ARCH Venture Partners, Mubadala, RA Capital Management, TCG and TCG Crossover.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$430Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $156M sold
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Ollin Biosciences's investors include ARCH Venture Partners, Mubadala, RA Capital Management, TCG and TCG Crossover.
Ollin Biosciences has raised $430M across 2 rounds since 2025.
Ollin Biosciences's most recent round was a Series B of $330M in Jun 2026.
Its most recent round, $330M in Jun 2026, is also its largest on record.
Ollin Biosciences's first round on record, in Sept 2025, was backed by ARCH Venture Partners and Mubadala.
Ollin Biosciences's latest named round is a Series B, in Jun 2026.
Ollin Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.